CONTINUATION OF TYROSINE KINASE INHIBITORS AFTER CHEMOTHERAPY IN PH plus ACUTE LYMPHOBLASTIC LEUKEMIA

被引：0
|
作者：
Smith, Stephanie [1 ]
Aftandilian, Catherine [1 ]
机构：
[1] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA
来源：
PEDIATRIC BLOOD & CANCER | 2019年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
010
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Upfront treatment with the first and second-generation tyrosine kinase inhibitors in Ph-positive acute lymphoblastic leukemia
    Yu, Guopan
    Chen, Fang
    Yin, Changxin
    Liu, Qifa
    Sun, Jing
    Xuan, Li
    Fan, Zhiping
    Wang, Qiang
    Liu, Xiaoli
    Jiang, Qianli
    Xu, Dan
    ONCOTARGET, 2017, 8 (63): : 107022 - 107032
  • [22] Efficacy of tyrosine kinase inhibitors in Ph-like acute lymphoblastic leukemia harboring ABL-class rearrangements
    Tanasi, Ilaria
    Ba, Ibrahima
    Sirvent, Nicolas
    Braun, Thorsten
    Cuccuini, Wendy
    Ballerini, Paola
    Duployez, Nicolas
    Tanguy-Schmidt, Aline
    Tamburini, Jerome
    Maury, Sebastien
    Dore, Eric
    Himberlin, Chantal
    Duclos, Cedric
    Chevallier, Patrice
    Rousselot, Philippe
    Bonifacio, Massimiliano
    Cave, Helene
    Baruchel, Andre
    Dombret, Herve
    Soulier, Jean
    Landman-Parker, Judith
    Boissel, Nicolas
    Clappier, Emmanuelle
    BLOOD, 2019, 134 (16) : 1351 - 1355
  • [23] The efficacy of tyrosine kinase inhibitors with steroid in phi- acute lymphoblastic leukemia.
    Gurman, Gunhan
    Merter, Mustafa
    Atilla, Erden
    Sahin, Ugur
    Topcuoglu, Pervin
    Arslan, Onder
    Ozcan, Muhit
    Ilhan, Osman
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [24] Role of Tyrosine Kinase Inhibitors in the Management of Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia
    Michael S. Mathisen
    Susan O’Brien
    Deborah Thomas
    Jorge Cortes
    Hagop Kantarjian
    Farhad Ravandi
    Current Hematologic Malignancy Reports, 2011, 6
  • [25] Relapse prevention with second generation tyrosine kinase inhibitors for Ph plus ve acute leukemia after allogenic stem cell transplantation.
    Anwer, Faiz K.
    Warraich, Zabih
    Sohail, Atif
    Thai, Theresa
    Latif, Azka
    Kapoor, Vikas
    Maher, Keri Renee
    Warraich, Faiza Hassan
    Warraich, Sami
    Baig, Zeeshan
    Mushtaq, Adeela
    Tenneti, Pavan
    McBride, Ali
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [26] Early Maintenance with Tyrosine Kinase Inhibitors Post Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Improves Survival in Ph plus Acute Lymphoblastic Leukemia (ALL) Patients
    Gowda, Lohith
    Alijadayeh, Majdi
    Marin, David Costa
    Ledesma, Celina
    Rondon, Gabriela
    Popat, Uday
    Alousi, Amin M.
    Oran, Betul
    Shah, Mithun Vinod
    Ahmed, Sairah
    Kanagal-Shamanna, Rashmi
    Ciurea, Stefan O.
    Shpall, Elizabeth J.
    Luthra, Raja
    Hosing, Chitra
    Qazilbash, Muzaffar H.
    Rezvani, Katy
    Jabbour, Elias J.
    Patel, Keyur P.
    Ravandi, Farhad
    Kantarjian, Hagop M.
    Champlin, Richard E.
    Kebriaei, Partow
    BLOOD, 2017, 130
  • [27] Peroxiredoxin-1 knockout negatively affects the viability of ph plus B-cell acute lymphoblastic leukemia cells and sensitizes them to tyrosine kinase inhibitors
    Hunia, J.
    Komorowski, L.
    Szczygiel, K.
    Firczuk, M.
    ANNALS OF ONCOLOGY, 2023, 34 : S210 - S210
  • [28] PDGFRB mutation and tyrosine kinase inhibitor resistance in Ph-like acute lymphoblastic leukemia
    Zhang, Yingchi
    Gao, Yufeng
    Zhang, Hui
    Zhang, Jingliao
    He, Fuhong
    Hnizda, Ales
    Qian, Maoxiang
    Liu, Xiaoming
    Gocho, Yoshihiro
    Pui, Ching-Hon
    Cheng, Tao
    Wang, Qianfei
    Yang, Jun J.
    Zhu, Xiaofan
    Liu, Xin
    BLOOD, 2018, 131 (20) : 2256 - 2261
  • [29] T-Cell Suppression By Src/ABL Kinase Inhibitors When Combined with Blinatumomab in Ph plus Acute Lymphoblastic Leukemia
    Leonard, Jessica
    Kosaka, Yoko
    Malla, Pavani
    Hayes-Lattin, Brandon
    Lamble, Adam J.
    Druker, Brian J.
    Tyner, Jeffrey W.
    Chang, Bill H.
    Lind, Evan F.
    BLOOD, 2018, 132
  • [30] Role of Tyrosine Kinase Inhibitors in the Management of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
    Mathisen, Michael S.
    O'Brien, Susan
    Thomas, Deborah
    Cortes, Jorge
    Kantarjian, Hagop
    Ravandi, Farhad
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2011, 6 (03) : 187 - 194
12345